241
Participants
Start Date
February 29, 2016
Primary Completion Date
July 31, 2019
Study Completion Date
July 31, 2019
Personalised medicine (Salmeterol)
If participants require add-on medication and have the Gly/Gly variant on the ADRB2, salmeterol will be prescribed.
Personalised medicine (Montelukast)
If participants require add-on medication and have the Arg/Arg or Arg/Gly variant on the ADRB2, montelukast will be prescribed.
Standard care
If participants require add-on medication in the arm, they will be prescribed either salmeterol or montelukast according to health professional's choice based on current guidelines.
Brighton & Sussex University Hospitals NHS Trust, Brighton
Kent, Surrey & Sussex CCGs, Gillingham
NHS Grampian, Aberdeen
NHS Tayside, Dundee
Bart's Health NHS Trust, London
University of Sussex
OTHER